wrap-up lot move piec fy
guid refin stori stay intact
mostli expect organ led consum
report organ sale growth yoy report revenu
ahead our/street est key companion
anim group recur revenu unit grew organ strong growth
consum off-set softer refer lab ou margin came slightli ahead
expect bottom line ep vs our/street estim
although approxim beat tie lower interest
expens tax-rat see first look addit detail result
biz still perform well ou ref lab focu
note part core busi continu impress
recur revenu post best year sinc consum finish
year particularli good note buoy sdma slide sedivu
pocket soft continu refer lab msd
follow lsd select market lag us robust mid-
teen idxx emphasi drive in-clinic/point-of-car placement revenu
seem increasingli like ou ref lab total refer lab
total compani revenu remain somewhat subdu throughout
myriad guid updat see stori unchang
neg reaction print seem larg driven number
refin guid total compani organ sale growth
unchang see recur vs prior
constant currenc opm expans vs prior follow
convers see chang indic materi
chang outlook reflect fine-tun model follow
result slightli stronger finish consum pull-through temper
expect ou ref lab slightli higher spend adjust sale
estim slightli lower core off-set less fx ep unchang
reiter buy rate po stay still base price-to-earnings
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
lead provid diagnost
inform technolog product servic
pet product anim health water qualiti
milk safeti human point-of-car diagnost
market leader thank rich new
product cycl posit trend companion
anim health market compani look well
posit continu strong growth trajectori
share trade premium peer
compani histor trend believ
premium well-deserv compani long-
term runway continu out-perform
driven new product launch industry-
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
share trade signific premium broader anim health peer
group histor level howev given mani posit secular product
tailwind compani current enjoy believ premium valuat justifi
po base ep estim in-lin histor trend
observ high growth life scienc diagnost tool compani broader
downsid risk po lower spend vet servic event
econom slowdown slower-than-expect uptak new product ou expans
competit lower-than-expect margin expans weather disrupt currenc
michael ryskin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
